Build status - In Progress

Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump

Recruiting
99 years or below
All
1 Location

Brief description of study

The HeartMate 3 requires medicines to keep your blood from clotting knowing as “blood thinners” which can both be anticoagulants and antiplatelet drugs. The standard drugs given when you have the HeartMate 3 are warfarin and aspirin. This study is investigating whether the combination of these drugs as compared to warfarin alone causes more bleeding without the benefit of preventing more blood clots.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Heart Failure
  • Age: 99 years or below
  • Gender: All

Subject will HeartMate

Updated on 04 Aug 2024. Study ID: 843216

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center